The key opinion leader of key opinion leaders. Or Boss of Bosses, if you prefer. In any case, take a peek at the following from Charles Nemeroff's page on the University of Miami's website. Seems like something must have happened in 2006 to slow down Chuck's momentum...

What? This is old news? Yeah, I know. But I just hadn't written much about our friends in the world of drug sales/"academics" lately, so I just had to do this.

Pharmaceutical and Clinical Research Company Scientific Advisory Boards
Abbott Laboratories
- Consultant, Abbott Laboratories, Diagnostics Division, 1986-1992.
- Research and Education Advisory Board for Psychiatry
- Member, 1990 - 2006
- Executive Board, 1991 - 1993, 2003 - 2006
-Antidepressant Advisory Board, 1991 - 1992
ACADIA Pharmaceuticals Clinical Advisory Board
- Member, 2000 - 2006.
AstraZeneca Pharmaceuticals
- Psychiatry Advisory Board, 1997 - 2001.
- Chairman, 1999 - 2002.
- Neuroscience Scientific Advisory Board, 1999 - present.
Bristol-Myers-Squibb
- Antipsychotic Advisory Board, 2003 - 2006.
- Antidepressant Advisory Board, 2003 - 2006.
- EMSAM Advisory Board - Chairman, 2005-2006.
Cephalon Pharmaceuticals
- Scientific Advisory Board, 2002
Comprehensive Neuroscience, Inc.
- Scientific Advisory Board, 1999 - 2004.
Corcept
- Scientific Advisory Board, 2001 - 2006
Cyberonics
- Scientific Advisory Board, 2002 - 2006.
- Chair, Mechanism of Action Board, 2003 - 2006.
Cypress Biosciences, Inc.
- Board of Directors, 2001 - 2004
- Consultant, 2004 - 2006
Eli Lilly and Company
- Psychiatry Advisory Board, 1990 - 2000.
- Bipolar Advisory Board, 1998 - 1999.
- Consultant, 2002 - 2003.
- Global Neuroscience Advisory Board, 2005 - 2006.
Forest Laboratories
- Citalopram Clinical Advisory Board, 1997 - 2002.
- Psychiatry Scientific Advisory Board, Chairman, 1999 – 2008.
GlaxoSmithKline Advisory Board of Psychiatrists
- Chairman, 1991 - 2004.
Janssen Pharmaceuticals
- Mood Disorders Advisory Board, Member and Chairman, 1998 - 2004.
- Topiramate Advisory Board, Member and Chairman, 1999 - 2001.
- Antipsychotic Advisory Board, Member, 1999 - present.
Johnson & Johnson Scientific Advisory Board, 2007- present.
Lundbeck
- Consultant, 2006
Merck Sharp & Dohme Research Laboratories
- Consultant, Neuroscience Research Center, 1994.
- Mood Disorders Advisory Board, 1999 - 2003.
Merck-MedCo Mental Health Advisory Board
- Member, 1996 – 1998
Mt. Cook Pharma
- Board of Directors, 2007 - Present
Neurocrine Biosciences
- Scientific Advisory Board, 1994 - 2004.
Neuronetics
- Scientific Advisory Board, 2006
Novadel Pharma
- Board of Directors, 2003 - present
- Chair, Scientific Advisory Committee
- Member, Compensation Committee
- Member, Nominating Committee
Novartis Pharmaceutical Company
- Bipolar Advisory Board Chairman, 2001 - 2003.
- Pediatric Bipolar Advisory Board, 2002 - 2003.
- Antidepressant Advisory Board, 2006.
Organon Pharmaceuticals Psychiatry Advisory Board
- Member, 1997 - 2004.
Otsuka Psychiatry Advisory Board
- Chairman, 2003 - 2006.
PharmaNeuroboost
- Scientific Advisory Board, 2006 – present.
Pfizer Pharmaceuticals
- Clinical Neuroscience Advisory Board, 2004 - 2006.
- Chair, Antipsychotic Advisory Board, 2004 - 2006.
Quintiles Scientific Advisory Board, 2004 - present
Revaax
- Stockholder
Roche Laboratories, a Division of Hoffman-LaRoche, Inc.
- Mania Advisory Board, 1993.
- Pharmocogenomics Advisory Board, 2006
Sanofi/Synthelabo
- Psychiatry Advisory Board, 2002 - 2005.
SciRex
- Scientific Advisory Board, 1999 - 2003.
Solvay Pharmaceuticals Psychiatry Advisory Board
- Member, 1991 - 1999.
- Chairman, 1991 - 1999.
- Antipsychotic Advisory Board, 2005 - 2006.
Somerset Pharmaceuticals Psychiatry Advisory Board
- Chair, 2000 - 2004.
Vela Pharmaceuticals
- Scientific Advisory Board, 2001 - 2002.
Wyeth-Ayerst Psychiatric Advisory Board
- Chairman and Member, 1995 - 2002.